This issue of McDermott’s Healthcare Regulatory Check-Up highlights regulatory activity for June 2024. We discuss several US Department of Health and Human Services (HHS) agency actions, including guidance regarding hospital price transparency, e-prescribing standards, Medicare Part B enrollment for pharmacies, Ryan White HIV/AIDS program funds, open payments, and the Merit-based Incentive Payment System (MIPS) final score review period. Additionally, we discuss two favorable Office of Inspector General (OIG) advisory opinions and several criminal and civil enforcement actions pertaining to healthcare fraud, including alleged violations under the False Claims Act (FCA), federal Anti-Kickback Statute (AKS) and Physician Self-Referral Law (Stark Law). Finally, we highlight a few material regulatory developments that impact the healthcare industry and discuss key decisions rendered by federal courts.
